AKT1 and prostate intraepithelial neoplasia: In contrast, PTEN-deficient tumors and AKT1-induced prostate intraepithelial neoplasia are sensitive to inhibition of mTOR, which is a downstream effector of the PI3K/AKT pathway [38,  51].